Sessile serrated adenoma/polyps(SSA/P)
Conditions
Interventions
Sponsors
NTT Medical Center Tokyo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with 10mm or more SSA/P
Exclusion criteria
Exclusion criteria: 1. Inflammatory bowel diseases 2. Hb < 9 g/dl 3. PT-INR > = 3 4. Pregnant women 5. Patients with severe heart/kidney/liver diseases 6. Patients in disagreement with informed consent 7. Others
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The presence of residual serrated neoplasia in biopsy specimens | — |
Secondary
| Measure | Time frame |
|---|---|
| The rate of adverse events, Procedure time, Diagnostic predictive value | — |
Countries
Japan
Contacts
Public ContactKimoto Yoshiaki
NTT Medical Center Tokyo Department of Gastroenterology
Outcome results
None listed